Aperio HALO AP, developed by Indica Labs in partnership with Leica Biosystems, is an AI-powered, pathologist-centric image management system built to optimize clinical workflows in anatomic pathology. It is designed for efficient on-screen slide review, unifying patient data, whole slide images (WSI), and AI-driven analytics into a single, intuitive, case-centric interface. The platform supports a variety of clinical and research workflows, including primary diagnosis (via the FDA-cleared HALO AP Dx version or CE-IVDR marked HALO AP), Multidisciplinary Team Meetings (MDTs), consultations, and clinical trials.
Key capabilities include:
- On-Screen Diagnosis & Review: Allows pathologists to review slides remotely the moment they are available, increasing efficiency and eliminating the logistics of physical slide shipping.
- Integrated Reporting: Clinicians can create and customize synoptic reports that are seamlessly displayed alongside case images for a holistic review of pathology data.
- Collaboration & Conferencing: Features built-in Case Conferencing for real-time, secure sharing and discussion of slides with internal and external colleagues, and supports blind scoring for clinical trials.
- AI Ecosystem: Seamless integration with the Aperio AI Store (and HALO Clinical AI) provides pathologists with a curated menu of powerful, third-party AI tools and algorithms, enhancing diagnostic accuracy and streamlining workflows.
- Interoperability: Utilizes open, API-first technology to support bi-directional connectivity with existing Laboratory Information Systems (LIS/LIMS), DICOM-compatible scanners, and PACS/VNA systems.
Deployment is flexible, offering secure cloud (including AWS S3/Glacier for archiving) or on-premises installations to integrate seamlessly within a laboratory's existing IT framework. The platform is targeted at large pathology labs, hospitals, research organizations, and pharmaceutical companies.